BRCN.F Stock Overview
Develops plant proteins and ingredients for use in the food and beverage industries in Canada. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Burcon NutraScience Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.054 |
52 Week High | CA$0.32 |
52 Week Low | CA$0.015 |
Beta | 2.7 |
1 Month Change | -41.83% |
3 Month Change | -57.47% |
1 Year Change | -74.60% |
3 Year Change | -95.77% |
5 Year Change | -92.90% |
Change since IPO | -99.46% |
Recent News & Updates
Recent updates
Burcon NutraScience falls 23% postmarket on delisting of stock from Nasdaq Capital Market
Sep 02Burcon NutraScience GAAP EPS of -C$0.04, revenue of C$90.54K
Aug 15Burcon: Partner Bunge's $500 Million To $1 Billion Of Growth Capex Within Alternative Proteins Bodes Well
May 12Burcon NutraScience: Achieved Several Key Milestones In 1H 2021, Significant Opportunity Ahead
Sep 03Shareholder Returns
BRCN.F | US Chemicals | US Market | |
---|---|---|---|
7D | -4.8% | -4.3% | -2.4% |
1Y | -74.6% | -3.4% | 23.4% |
Return vs Industry: BRCN.F underperformed the US Chemicals industry which returned -3.4% over the past year.
Return vs Market: BRCN.F underperformed the US Market which returned 23.3% over the past year.
Price Volatility
BRCN.F volatility | |
---|---|
BRCN.F Average Weekly Movement | 27.8% |
Chemicals Industry Average Movement | 5.5% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BRCN.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BRCN.F's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | 25 | Kip Underwood | www.burcon.ca |
Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company offers Peazazz and Peazac, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products; Puratein, a canola protein isolate use for meat alternatives, such as burgers, sausages, and nutrition bars; and Supertein, a canola protein for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows, and ready-to-mix beverages, whipped toppings, and plant-based bars. It also provides Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods; and CLARISOY, a soy protein for use in sports nutrition beverages, citrus-based drinks, fruit-flavored beverages, lemonades, powdered beverage mixes, and non-beverage plant-based products.
Burcon NutraScience Corporation Fundamentals Summary
BRCN.F fundamental statistics | |
---|---|
Market cap | US$7.94m |
Earnings (TTM) | -US$5.79m |
Revenue (TTM) | US$192.81k |
41.2x
P/S Ratio-1.4x
P/E RatioIs BRCN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BRCN.F income statement (TTM) | |
---|---|
Revenue | CA$277.08k |
Cost of Revenue | CA$372.25k |
Gross Profit | -CA$95.17k |
Other Expenses | CA$8.23m |
Earnings | -CA$8.32m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.058 |
Gross Margin | -34.35% |
Net Profit Margin | -3,004.51% |
Debt/Equity Ratio | 404.5% |
How did BRCN.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 17:13 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Burcon NutraScience Corporation is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Tania Armstrong-Whitworth | Canaccord Genuity |
Jacob Bout | CIBC Capital Markets |
Ammar Shah | Eight Capital |